Lee, M., Cho, H. J., Hong, J. Y., Lee, J., Park, S. H., Park, J. O., . . . Kim, S. T. (2020). Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment. Ther Adv Med Oncol.
Styl ChicagoLee, Min-Sang, et al. "Clinical and Molecular Distinctions in Patients With Refractory Colon Cancer Who Benefit From Regorafenib Treatment." Ther Adv Med Oncol 2020.
Citace podle MLALee, Min-Sang, et al. "Clinical and Molecular Distinctions in Patients With Refractory Colon Cancer Who Benefit From Regorafenib Treatment." Ther Adv Med Oncol 2020.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..